Works matching IS 03407004 AND DT 2023 AND VI 72 AND IP 11

Results: 36

Metabolic diversity of tumor-infiltrating T cells as target for anti-immune therapeutics.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3453, doi. 10.1007/s00262-023-03540-1

By:

Li, Peipei;
Li, Fangchao;
Zhang, Yanfei;
Yu, Xiaoyang;
Li, Jingjing

Publication type:

Article

Extended duration of treatment using reduced-frequency dosing of anti-PD-1 therapy in patients with advanced melanoma and Merkel cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3839, doi. 10.1007/s00262-023-03539-8

By:

Tachiki, Lisa May Ling;
Hippe, Daniel S.;
Williams Silva, Karly;
Hall, Evan Thomas;
McCamy, William;
Fritzsche, Dane;
Perdue, Andrea;
Majovski, Julia;
Pulliam, Thomas;
Goldstein, Daniel A.;
Veatch, Joshua;
Ho, Joel;
Nghiem, Paul T.;
Thompson, John A.;
Bhatia, Shailender

Publication type:

Article

GK-1 effectively reduces angiogenesis and prevents T cell exhaustion in a breast cancer murine experimental model.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3825, doi. 10.1007/s00262-023-03538-9

By:

Hernández-Aceves, Juan A.;
Cervantes-Torres, Jacquelynne;
Torres-García, Diana;
Zuñiga-Flores, Francisco J.;
Patiño-Chávez, Osiris J.;
Peña Agudelo, Jorge A.;
Aguayo-Flores, José Eduardo;
Garfias, Yonathan;
Montero-León, Laura;
Romero-Romero, Laura;
Pérez-Torres, Armando;
Fragoso, Gladis;
Sciutto, Edda

Publication type:

Article

Targeting GD2 after allogeneic SCT: effector cell composition defines the optimal use of ch14.18 and the bispecific antibody construct NG-CU (GD2-CD3).

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3813, doi. 10.1007/s00262-023-03536-x

By:

Arendt, A.-M.;
Heubach, F.;
Maier, C. P.;
Giardino, S.;
Jung, G.;
Kowalewski, E.;
Rabsteyn, A.;
Amorelli, G.;
Seitz, C.;
Schlegel, P.;
Handgretinger, R.;
Lang, P.

Publication type:

Article

Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC).

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3803, doi. 10.1007/s00262-023-03533-0

By:

Vita, Emanuele;
Stefani, Alessio;
Piro, Geny;
Mastrantoni, Luca;
Cintoni, Marco;
Cicchetti, Giuseppe;
Sparagna, Ileana;
Monaca, Federico;
Horn, Guido;
Russo, Jacopo;
Barone, Diletta;
Di Salvatore, Mariantonietta;
Trisolini, Rocco;
Lococo, Filippo;
Mazzarella, Ciro;
Cancellieri, Alessandra;
Carbone, Carmine;
Larici, Anna Rita;
Mele, Maria Cristina;
Pilotto, Sara

Publication type:

Article

Radiation-associated secondary malignancies: a novel opportunity for applying immunotherapies.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3445, doi. 10.1007/s00262-023-03532-1

By:

Atajanova, Tavus;
Rahman, Md Mahfuzur;
Konieczkowski, David J.;
Morris, Zachary S.

Publication type:

Article

PD-L1-expressing cancer-associated fibroblasts induce tumor immunosuppression and contribute to poor clinical outcome in esophageal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3787, doi. 10.1007/s00262-023-03531-2

By:

Kawasaki, Kento;
Noma, Kazuhiro;
Kato, Takuya;
Ohara, Toshiaki;
Tanabe, Shunsuke;
Takeda, Yasushige;
Matsumoto, Hijiri;
Nishimura, Seitaro;
Kunitomo, Tomoyoshi;
Akai, Masaaki;
Kobayashi, Teruki;
Nishiwaki, Noriyuki;
Kashima, Hajime;
Maeda, Naoaki;
Kikuchi, Satoru;
Tazawa, Hiroshi;
Shirakawa, Yasuhiro;
Fujiwara, Toshiyoshi

Publication type:

Article

Dual targeting ovarian cancer by Muc16 CAR T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3773, doi. 10.1007/s00262-023-03529-w

By:

Mun, Sung Soo;
Meyerberg, Jeremy;
Peraro, Leila;
Korontsvit, Tatyana;
Gardner, Thomas;
Malviya, Manish;
Kyi, Chrisann;
O'Cearbhaill, Roisin E.;
Liu, Cheng;
Dao, Tao;
Scheinberg, David A.

Publication type:

Article

Second-line immunosuppressant administration for steroid-refractory immune-related adverse events in patients with lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3765, doi. 10.1007/s00262-023-03528-x

By:

Ogusu, Shinsuke;
Harutani, Yuhei;
Tozuka, Takehiro;
Saito, Ryota;
Koyama, Junji;
Sakamoto, Hiroaki;
Sonoda, Tomoaki;
Tsuchiya-Kawano, Yuko;
Oba, Tomohiro;
Kudo, Keita;
Gyotoku, Hiroshi;
Nakatomi, Katsumi;
Ariyasu, Ryo

Publication type:

Article

Prognostic impact of soluble PD-L1 derived from tumor-associated macrophages in non-small-cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3755, doi. 10.1007/s00262-023-03527-y

By:

Teramoto, Koji;
Igarashi, Tomoyuki;
Kataoka, Yoko;
Ishida, Mitsuaki;
Hanaoka, Jun;
Sumimoto, Hidetoshi;
Daigo, Yataro

Publication type:

Article

Anti-CD79b/CD3 bispecific antibody combined with CAR19-T cells for B-cell lymphoma treatment.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3739, doi. 10.1007/s00262-023-03526-z

By:

Zheng, Wei-Wei;
Zhou, Hang;
Li, Ping;
Ye, Shi-Guang;
Abudureheman, Tuersunayi;
Yang, Li-Ting;
Qing, Kai;
Liang, Ai-Bin;
Chen, Kai-Ming;
Duan, Cai-Wen

Publication type:

Article

Combination therapy with dendritic cell loaded-exosomes supplemented with PD-1 inhibition at different time points have superior antitumor effect in hepatocellular carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3727, doi. 10.1007/s00262-023-03525-0

By:

Chang, Chunxiao;
Pei, Yanqing;
Zhang, Chuangnian;
Zhang, Wenyu;
Qin, Yibo;
Shi, Shengbin

Publication type:

Article

Cancer management during the COVID-19 world pandemic.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3427, doi. 10.1007/s00262-023-03524-1

By:

Sobhani, Navid;
Mondani, Giuseppina;
Roviello, Giandomenico;
Catalano, Martina;
Sirico, Marianna;
D'Angelo, Alberto;
Scaggiante, Bruna;
Generali, Daniele

Publication type:

Article

Real-world cohort study of PD-1 blockade plus lenvatinib for advanced intrahepatic cholangiocarcinoma: effectiveness, safety, and biomarker analysis.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3717, doi. 10.1007/s00262-023-03523-2

By:

Chao, Jiashuo;
Wang, Shanshan;
Wang, Hao;
Zhang, Nan;
Wang, Yunchao;
Yang, Xu;
Zhu, Chengpei;
Ning, Cong;
Zhang, Xinmu;
Xue, Jingnan;
Zhang, Longhao;
Piao, Mingjian;
Wang, Mingming;
Yang, Xiaobo;
Lu, Ling;
Zhao, Haitao

Publication type:

Article

Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3707, doi. 10.1007/s00262-023-03522-3

By:

Bersanelli, Melissa;
Cortellini, Alessio;
Leonetti, Alessandro;
Parisi, Alessandro;
Tiseo, Marcello;
Bordi, Paola;
Michiara, Maria;
Bui, Simona;
Cosenza, Agnese;
Ferri, Leonarda;
Giudice, Giulia Claire;
Testi, Irene;
Rapacchi, Elena;
Camisa, Roberta;
Vincenzi, Bruno;
Caruso, Giuseppe;
Rauti, Antonio Natale;
Arturi, Federica;
Tucci, Marco;
Santo, Valentina

Publication type:

Article

Reconstructing the immunosenescence core pathway reveals global characteristics in pan-cancer.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3693, doi. 10.1007/s00262-023-03521-4

By:

Zhang, Yakun;
Sun, Yue;
Gan, Jing;
Zhou, Hanxiao;
Guo, Shuang;
Wang, Xinyue;
Zhang, Caiyu;
Zheng, Wen;
Zhao, Xiaoxi;
Zhang, Yunpeng;
Ning, Shangwei;
Li, Xia

Publication type:

Article

Nomogram for predicting the prognosis of metastatic colorectal cancer patients treated with anti-PD1 therapy based on serum lipids analysis.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3683, doi. 10.1007/s00262-023-03519-y

By:

Xiao, Bijing;
Ouyang, Hui;
Gulizeba, Haimiti;
Fu, Haiyan;
Wang, Zhiqiang;
Huang, Yan

Publication type:

Article

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3665, doi. 10.1007/s00262-023-03518-z

By:

Fiala, Ondřej;
Buti, Sebastiano;
Takeshita, Hideki;
Okada, Yohei;
Massari, Francesco;
Palacios, Georgia Anguera;
Dionese, Michele;
Scagliarini, Sarah;
Büttner, Thomas;
Fornarini, Giuseppe;
Myint, Zin W.;
Galli, Luca;
Souza, Vinicius Carrera;
Pichler, Renate;
De Giorgi, Ugo;
Quiroga, María Natalia Gandur;
Gilbert, Danielle;
Popovic, Lazar;
Grande, Enrique;
Mammone, Giulia

Publication type:

Article

Intravenous injection of tumor extracellular vesicles suppresses tumor growth by reducing the regulatory T cell phenotype.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3651, doi. 10.1007/s00262-023-03517-0

By:

Kobayashi, Sanshiro;
Kondo, Naoyuki;
Tomiyama, Takashi;
Nakamura, Naohiro;
Masuda, Masataka;
Matsumoto, Yasushi;
Honzawa, Yusuke;
Tahara, Tomomitsu;
Ikeura, Tsukasa;
Fukui, Toshiro;
Okazaki, Kazuichi;
Naganuma, Makoto

Publication type:

Article

TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3405, doi. 10.1007/s00262-023-03516-1

By:

Sauer, Natalia;
Janicka, Natalia;
Szlasa, Wojciech;
Skinderowicz, Bartłomiej;
Kołodzińska, Katarzyna;
Dwernicka, Wioletta;
Oślizło, Małgorzata;
Kulbacka, Julita;
Novickij, Vitalij;
Karłowicz-Bodalska, Katarzyna

Publication type:

Article

Immune profile of patients with peritoneal carcinomatosis selected for CRS-HIPEC therapy.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3867, doi. 10.1007/s00262-023-03515-2

By:

Kleber, Julia;
Yang Zhou, Jordi;
Weber, Florian;
Bitterer, Florian;
Hauer, Patricia;
Kupke, Paul;
Kronenberg, Katharina;
Geissler, Edward K.;
Schlitt, Hans J.;
Hornung, Matthias;
Hutchinson, James A.;
Werner, Jens M.

Publication type:

Article

Pretreatment blast-to-lymphocyte ratio as a prognostic marker for CD19/CD3-bispecific T cell-engaging antibodies (blinatumomab) treatment against relapsed or refractory B-precursor acute lymphoblastic leukemia.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3861, doi. 10.1007/s00262-023-03514-3

By:

Shimazu, Yutaka;
Kitawaki, Toshio;
Kondo, Tadakazu;
Takaori-Kondo, Akifumi

Publication type:

Article

Comparison of the effectiveness of chemotherapy combined with immunotherapy and chemotherapy alone in advanced biliary tract cancer and construction of the nomogram for survival prediction based on the inflammatory index and controlling nutritional status score

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3635, doi. 10.1007/s00262-023-03513-4

By:

Zhang, Zhengfeng;
Wang, Dazhen;
Zhang, Jianji;
Ruan, Yuli;
Zhao, Lu;
Yang, Liu;
Liu, Ze;
Yang, Lei;
Lou, Changjie

Publication type:

Article

Th1 cytokines in pediatric acute lymphoblastic leukemia.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3621, doi. 10.1007/s00262-023-03512-5

By:

Schober, Sarah;
Rottenberger, Jennifer M.;
Hilz, Johannes;
Schmid, Evi;
Ebinger, Martin;
Feuchtinger, Tobias;
Handgretinger, Rupert;
Lang, Peter;
Queudeville, Manon

Publication type:

Article

Transarterial interventional therapy combined with tyrosine kinase inhibitors with or without anti-PD-1 antibodies as initial treatment for hepatocellular carcinoma with major portal vein tumor thrombosis: a single-center retrospective study.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3609, doi. 10.1007/s00262-023-03511-6

By:

Yu, Wenchang;
Liu, Weifu;
Zhang, Kongzhi;
Chen, Shiguang;
Wang, Xiaolong

Publication type:

Article

Reovirus combined with a STING agonist enhances anti-tumor immunity in a mouse model of colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3593, doi. 10.1007/s00262-023-03509-0

By:

Sugimura, Naomi;
Kubota, Eiji;
Mori, Yoshinori;
Aoyama, Mineyoshi;
Tanaka, Mamoru;
Shimura, Takaya;
Tanida, Satoshi;
Johnston, Randal N.;
Kataoka, Hiromi

Publication type:

Article

Thrombotic risk of platinum combination chemotherapy with and without immune checkpoint inhibitors for advanced non-small cell lung cancer: a nationwide inpatient database study.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3581, doi. 10.1007/s00262-023-03508-1

By:

Iwai, Chikako;
Jo, Taisuke;
Konishi, Takaaki;
Fujita, Asahi;
Michihata, Nobuaki;
Matsui, Hiroki;
Fushimi, Kiyohide;
Yasunaga, Hideo

Publication type:

Article

A novel agonist of 4-1BB costimulatory receptor shows therapeutic efficacy against a tobacco carcinogen-induced lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3567, doi. 10.1007/s00262-023-03507-2

By:

Gulen, Ayse Ece;
Rudraboina, Rakesh;
Tarique, Mohammad;
Ulker, Vahap;
Shirwan, Haval;
Yolcu, Esma S.

Publication type:

Article

HLA-B*44 and the Bw4-80T motif are associated with poor outcome of relapse-preventive immunotherapy in acute myeloid leukemia.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3559, doi. 10.1007/s00262-023-03506-3

By:

Komic, Hana;
Hallner, Alexander;
Hussein, Brwa Ali;
Badami, Chiara;
Wöhr, Anne;
Hellstrand, Kristoffer;
Bernson, Elin;
Thorén, Fredrik B.

Publication type:

Article

Preferential B cell differentiation by combined immune checkpoint blockade for renal cell carcinoma is associated with clinical response and autoimmune reactions.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3543, doi. 10.1007/s00262-023-03505-4

By:

Uehara, Koki;
Tanoue, Kenro;
Yamaguchi, Kyoko;
Ohmura, Hirofumi;
Ito, Mamoru;
Matsushita, Yuzo;
Tsuchihashi, Kenji;
Tamura, Shingo;
Shimokawa, Hozumi;
Isobe, Taichi;
Shibata, Yoshihiro;
Ariyama, Hiroshi;
Tanaka, Risa;
Kusaba, Hitoshi;
Yamamoto, Hidetaka;
Oda, Yoshinao;
Akashi, Koichi;
Baba, Eishi

Publication type:

Article

Role of single-cell ferroptosis regulation in intercellular communication and skin cutaneous melanoma progression and immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3523, doi. 10.1007/s00262-023-03504-5

By:

Song, Binyu;
Peng, Yixuan;
Zheng, Yu;
Zhu, Yuhan;
Liu, Wei;
Wang, Kai;
Cui, Zhiwei;
Song, Baoqiang

Publication type:

Article

Deciphering the immune reaction leading to spontaneous melanoma regression: initial role of MHCII<sup>+</sup> CD163<sup>−</sup> macrophages.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3507, doi. 10.1007/s00262-023-03503-6

By:

Blanc, Fany;
Bertho, Nicolas;
Piton, Guillaume;
Leplat, Jean-Jacques;
Egidy, Giorgia;
Bourneuf, Emmanuelle;
Vincent-Naulleau, Silvia;
Prévost-Blondel, Armelle

Publication type:

Article

Systemic administration of STING agonist promotes myeloid cells maturation and antitumor immunity through regulating hematopoietic stem and progenitor cell fate.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3491, doi. 10.1007/s00262-023-03502-7

By:

Xu, Tianxiao;
Dai, Jie;
Tang, Lirui;
Sun, Linzi;
Si, Lu;
Guo, Jun

Publication type:

Article

Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3475, doi. 10.1007/s00262-023-03498-0

By:

Schmitt, C.;
Hoefsmit, E. P.;
Fangmeier, T.;
Kramer, N.;
Kabakci, C.;
Vera González, J.;
Versluis, J. M.;
Compter, A.;
Harrer, T.;
Mijočević, H.;
Schubert, S.;
Hundsberger, T.;
Menzies, A. M.;
Scolyer, R. A.;
Long, G. V.;
French, L. E.;
Blank, C. U.;
Heinzerling, L. M.

Publication type:

Article

BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3461, doi. 10.1007/s00262-023-03497-1

By:

Sun, Steven H.;
Angell, Colin D.;
Savardekar, Himanshu;
Sundi, Debasish;
Abood, David;
Benner, Brooke;
DiVincenzo, Mallory J.;
Duggan, Megan;
Choueiry, Fouad;
Mace, Thomas;
Trikha, Prashant;
Lapurga, Gabriella;
Johnson, Courtney;
Carlson, Erick J.;
Chung, Catherine;
Peterson, Blake R.;
Lianbo Yu;
Zhao, Jing;
Kendra, Kari L.;
Carson III, William E.

Publication type:

Article

Radiation-induced dormancy of intracerebral melanoma: endotoxin inflammation leads to both shortened tumor dormancy and long-term survival with localized senescence.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3851, doi. 10.1007/s00262-023-03481-9

By:

Ridwan, Sharif M.;
Emlein, Rose;
Mesbahi, Asghar;
Annabi, Andrew;
Hainfeld, James F.;
Smilowitz, Henry M.

Publication type:

Article